Semantic search

The following is a summary of information provided by the licensee via email and phone: A patient, accompanied by her daughter who is the patient's preferred translator, was receiving the first of four Lutathera infusions. The physician, registered nurse, nuclear medicine personnel and radiological safety team members were present for the infusion. The Lutathera infusion was performed per protocol without any issue. Post infusion it was determined through the patient's daughter that the patient had had a lanreotide injection last week on 1/12/23. Per protocol Lutathera is to be given four weeks after a lanreotide/octreotide injection has been administered. A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.

• * * RETRACTION ON 2/1/23 AT 1040 EST FROM SANDRA PHILLIPS TO ADAM KOZIOL * * *

The following information was provided by the licensee via telephone: Further review from hospital staff in coordination with NRC Medical Health Team determined this is not a medical event. Notified R1DO (Lally) and NMSS (email).